Françoise Baylis wonders how it is that in 14 months (from December 2015 to February 2017), the U.S. National Academy of Sciences and the U.S. National Academy of Medicine have moved human germline genome editing out of the category ‘irresponsible’ and into the category ‘permissible.’
Séverine Caluwaerts and Françoise Baylis lament the fact that in an epidemic as deadly as Ebola, pregnant women were denied access to potentially life-saving vaccination solely on the grounds of pregnancy.
Françoise Baylis discusses the response of the Canadian insurance industry to Bill S-201, An Act to prohibit and prevent genetic discrimination.
Alain Beaudet shares an excerpt of his speech, given at last week’s annual Forum of the Canadian Academy of Health Sciences, which outlines research priorities for indigenous health.
Françoise Baylis explains Canada’s regulatory framework for human-nonhuman chimera research and suggests that the proposed changes to the NIH guidelines to permit the funding of such research may have implications for Canadian research.